ARGOS THERAPEUTICS INC SEC Filings

Filed On	Filing
03 May 2019	8-K: Changes in Registrant's Certifying Accountant
14 Feb 2019	SC 13D/A
03 Dec 2018	8-K: Bankruptcy or Receivership; Departure/Election of Directors or Officers; Compensation
19 Nov 2018	FORM 10-Q
14 Nov 2018	FORM NT 10-Q
20 Aug 2018	FORM 10-Q
15 Aug 2018	FORM NT 10-Q
20 Jul 2018	8-K: Departure/Election of Directors or Officers; Compensation
19 Jul 2018	25-NSE
15 May 2018	FORM S-8
15 May 2018	FORM 10-Q
09 May 2018	CT ORDER
25 Apr 2018	Form 4: Abbey Jeffrey D, Director Returned 67,887 shares to the issuer
25 Apr 2018	Form 4: Katz Richard D, Vice President and CFO Returned 22,629 shares to the issuer
25 Apr 2018	Form 4: Harrelson Lori R., Vice President of Finance Returned 22,629 shares to the issuer
25 Apr 2018	Form 4: Nicolette Charles A., CSO and Vice President of R&D Returned 27,150 shares to the issuer
24 Apr 2018	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Departure/Election of Directors or Officers; Compensation +1 more
19 Apr 2018	8-K: Other Events
02 Apr 2018	424B5
02 Apr 2018	Form 4: Katz Richard D, Vice President and CFO Received 22,629 shares as a grant or award

Comments